{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T02:27:58Z","timestamp":1773023278838,"version":"3.50.1"},"reference-count":96,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":1075,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["17k0598"],"award-info":[{"award-number":["17k0598"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["li.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Laboratory Investigation"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1038\/s41374-019-0349-z","type":"journal-article","created":{"date-parts":[[2019,12,19]],"date-time":"2019-12-19T13:02:51Z","timestamp":1576760571000},"page":"207-217","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["TRPV2 channel as a possible drug target for the treatment of heart failure"],"prefix":"10.1016","volume":"100","author":[{"given":"Yuko","family":"Iwata","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeo","family":"Wakabayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masafumi","family":"Kitakaze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1038\/s41374-019-0349-z_bib1","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1002\/ejhf.822","article-title":"Do patients have worse outcomes in heart failure than in cancer? A primary care-based cohort study with 10-year follow-up in Scotland","volume":"19","author":"Mamas","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"10.1038\/s41374-019-0349-z_bib2","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0092-8674(01)00242-2","article-title":"The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms","volume":"104","author":"Seidman","year":"2001","journal-title":"Cell"},{"key":"10.1038\/s41374-019-0349-z_bib3","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"62","author":"Yancy","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1038\/s41374-019-0349-z_bib4","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/ejhf.592","volume":"18","author":"Ponikowski","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"10.1038\/s41374-019-0349-z_bib5","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1093\/eurheartj\/ehs257","article-title":"Mineralocorticoid receptor antagonists for heart failure with reduced ejection fraction: integrating evidence into clinical practice","volume":"33","author":"Zannad","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1038\/s41374-019-0349-z_bib6","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1161\/CIRCRESAHA.117.310230","article-title":"Calcium and excitation-contraction coupling in the heart","volume":"121","author":"Eisner","year":"2017","journal-title":"Circ Res"},{"key":"10.1038\/s41374-019-0349-z_bib7","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1007\/s00424-014-1469-3","article-title":"Ca handling during excitation-contraction coupling in heart failure","volume":"466","author":"Zima","year":"2014","journal-title":"Pflugers Arch"},{"key":"10.1038\/s41374-019-0349-z_bib8","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.yjmcc.2011.01.012","article-title":"CaMKII in myocardial hypertrophy and heart failure","volume":"51","author":"Anderson","year":"2011","journal-title":"J Mol Cell Cardiol"},{"key":"10.1038\/s41374-019-0349-z_bib9","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1083\/jcb.200301101","article-title":"A novel mechanism of myocyte degeneration involving the Ca2+-permeable growth factor-regulated channel","volume":"161","author":"Iwata","year":"2003","journal-title":"J Cell Biol"},{"key":"10.1038\/s41374-019-0349-z_bib10","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1161\/01.RES.0000097263.10220.0C","article-title":"TRPV2 is a component of osmotically sensitive cation channels in murine aortic myocytes","volume":"93","author":"Muraki","year":"2003","journal-title":"Circ Res"},{"key":"10.1038\/s41374-019-0349-z_bib11","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1093\/cvr\/cvt163","article-title":"Blockade of sarcolemmal TRPV2 accumulation inhibits progression of dilated cardiomyopathy","volume":"99","author":"Iwata","year":"2013","journal-title":"Cardiovasc Res"},{"key":"10.1038\/s41374-019-0349-z_bib12","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1161\/CIRCRESAHA.106.146670","article-title":"Knock-in mouse model of dilated cardiomyopathy caused by troponin mutation","volume":"101","author":"Du","year":"2007","journal-title":"Circ Res"},{"key":"10.1038\/s41374-019-0349-z_bib13","doi-asserted-by":"crossref","first-page":"550","DOI":"10.2183\/pjab.87.550","article-title":"Adult onset cardiac dilatation in a transgenic mouse line with Galbeta1,3GalNAc alpha2,3-sialyltransferase II (ST3Gal-II) transgenes: a new model for dilated cardiomyopathy","volume":"87","author":"Suzuki","year":"2011","journal-title":"Proc Jpn Acad Ser B Phys Biol Sci"},{"key":"10.1038\/s41374-019-0349-z_bib14","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ceca.2016.01.001","article-title":"Axial stretch-dependent cation entry in dystrophic cardiomyopathy: Involvement of several TRPs channels","volume":"59","author":"Aguettaz","year":"2016","journal-title":"Cell Calcium"},{"key":"10.1038\/s41374-019-0349-z_bib15","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1093\/cvr\/cvv021","article-title":"Dystrophic cardiomyopathy: role of TRPV2 channels in stretch-induced cell damage","volume":"106","author":"Lorin","year":"2015","journal-title":"Cardiovasc Res"},{"key":"10.1038\/s41374-019-0349-z_bib16","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1097\/HJH.0000000000001213","article-title":"Transient receptor potential vanilloid 2 function regulates cardiac hypertrophy via stretch-induced activation","volume":"35","author":"Koch","year":"2017","journal-title":"J Hypertens"},{"key":"10.1038\/s41374-019-0349-z_bib17","doi-asserted-by":"crossref","first-page":"e105055","DOI":"10.1371\/journal.pone.0105055","article-title":"The transient receptor potential vanilloid 2 cation channel is abundant in macrophages accumulating at the peri-infarct zone and may enhance their migration capacity towards injured cardiomyocytes following myocardial infarction","volume":"9","author":"Entin-Meer","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1038\/s41374-019-0349-z_bib18","doi-asserted-by":"crossref","first-page":"e0177132","DOI":"10.1371\/journal.pone.0177132","article-title":"TRPV2 knockout mice demonstrate an improved cardiac performance following myocardial infarction due to attenuated activity of peri-infarct macrophages","volume":"12","author":"Entin-Meer","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1038\/s41374-019-0349-z_bib19","doi-asserted-by":"crossref","first-page":"13680","DOI":"10.1002\/jcb.28641","article-title":"miR-202-5p protects rat against myocardial ischemia reperfusion injury by downregulating the expression of Trpv2 to attenuate the Ca (2+) overload in cardiomyocytes","volume":"120","author":"Li","year":"2019","journal-title":"J Cell Biochem"},{"key":"10.1038\/s41374-019-0349-z_bib20","first-page":"194","article-title":"Overexpression of the amino-terminal domain of TRPV2 has the beneficial effect for dilated cardiomyopathy mice with mutation of troponin T","volume":"124","author":"Kamauchi","year":"2014","journal-title":"J Pharmacol Sci"},{"key":"10.1038\/s41374-019-0349-z_bib21","doi-asserted-by":"crossref","unstructured":"Iwata Y, Hirayama M, Ito S, Kitakaze M. Treatment with TRPV2 antibody ameliorates the severity of heart failure in dilated cardiomyopathic hamsters. In: 18th World Congress of Basic and Clinical Pharmacology. WCP2018Kyoto. Japan (Kyoto), 2018.","DOI":"10.1254\/jpssuppl.WCP2018.0_PO1-2-27"},{"key":"10.1038\/s41374-019-0349-z_bib22","doi-asserted-by":"crossref","unstructured":"Iwata Y, Hirayama M, Ito S, Kitakaze M. Inhibition of TRPV2 prevents the progression of murine heart failure. In: The 92nd Annual Meeting of the Japanese Pharmacological Society. Japan (Osaka), 2019.","DOI":"10.1254\/jpssuppl.92.0_3-P-061"},{"key":"10.1038\/s41374-019-0349-z_bib23","doi-asserted-by":"crossref","first-page":"11977","DOI":"10.1161\/circ.130.suppl_2.11977","article-title":"Transient receptor potential vanilloid 2 antagonist, ameliorates end-stage heart failure of mice with dilated cardiomyopathy","volume":"130","author":"Iwata","year":"2014","journal-title":"Circulation"},{"issue":"10","key":"10.1038\/s41374-019-0349-z_bib24","doi-asserted-by":"crossref","first-page":"S198","DOI":"10.1016\/j.cardfail.2014.07.368","article-title":"Tranilast, Orally Active TRPV2 Antagonist, Ameliorates End-stage Heart Failure in Mice with Dilated Cardiomyopathy","volume":"20","author":"Komamura","year":"2014","journal-title":"Journal of Cardiac Failure"},{"key":"10.1038\/s41374-019-0349-z_bib25","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s10741-010-9168-4","article-title":"Proinflammatory cytokines in heart failure: double-edged swords","volume":"15","author":"Hedayat","year":"2010","journal-title":"Heart Fail Rev"},{"key":"10.1038\/s41374-019-0349-z_bib26","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1159\/000338166","article-title":"Inflammatory cytokines in heart failure: mediators and markers","volume":"122","author":"Gullestad","year":"2012","journal-title":"Cardiology"},{"key":"10.1038\/s41374-019-0349-z_bib27","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.3389\/fimmu.2018.01273","article-title":"\"Immuno-transient receptor potential ion channels\": the role in monocyte- and macrophage-mediated inflammatory responses","volume":"9","author":"Santoni","year":"2018","journal-title":"Front Immunol"},{"key":"10.1038\/s41374-019-0349-z_bib28","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2164-15-509","article-title":"The transcriptomic profile of peripheral blood nuclear cells in dogs with heart failure","volume":"15","author":"Hulanicka","year":"2014","journal-title":"BMC Genomics"},{"key":"10.1038\/s41374-019-0349-z_bib29","doi-asserted-by":"crossref","first-page":"311","DOI":"10.2169\/internalmedicine.8651-16","article-title":"A pilot study of tranilast for cardiomyopathy of muscular dystrophy","volume":"57","author":"Matsumura","year":"2018","journal-title":"Intern Med"},{"key":"10.1038\/s41374-019-0349-z_bib30","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3389\/fimmu.2013.00034","article-title":"The role of transient receptor potential vanilloid type-2 ion channels in innate and adaptive immune responses","volume":"4","author":"Santoni","year":"2013","journal-title":"Front Immunol"},{"key":"10.1038\/s41374-019-0349-z_bib31","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.bbrc.2010.06.082","article-title":"Role of transient receptor potential vanilloid 2 in LPS-induced cytokine production in macrophages","volume":"398","author":"Yamashiro","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1038\/s41374-019-0349-z_bib32","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/jcp.20883","article-title":"Chemotactic peptide fMetLeuPhe induces translocation of the TRPV2 channel in macrophages","volume":"210","author":"Nagasawa","year":"2007","journal-title":"J Cell Physiol"},{"key":"10.1038\/s41374-019-0349-z_bib33","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ceca.2011.12.012","article-title":"Translocation of calcium-permeable TRPV2 channel to the podosome: Its role in the regulation of podosome assembly","volume":"51","author":"Nagasawa","year":"2012","journal-title":"Cell Calcium"},{"key":"10.1038\/s41374-019-0349-z_bib34","doi-asserted-by":"crossref","first-page":"e12296","DOI":"10.14814\/phy2.12296","article-title":"Translocation of TRPV2 channel induced by focal administration of mechanical stress","volume":"3","author":"Nagasawa","year":"2015","journal-title":"Physiol Rep"},{"key":"10.1038\/s41374-019-0349-z_bib35","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/ni.1842","article-title":"TRPV2 has a pivotal role in macrophage particle binding and phagocytosis","volume":"11","author":"Link","year":"2010","journal-title":"Nat Immunol"},{"key":"10.1038\/s41374-019-0349-z_bib36","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1161\/CIRCRESAHA.116.309001","article-title":"Proliferation and recruitment contribute to myocardial macrophage expansion in chronic heart failure","volume":"119","author":"Sager","year":"2016","journal-title":"Circ Res"},{"key":"10.1038\/s41374-019-0349-z_bib37","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.cell.2017.03.050","article-title":"Macrophages facilitate electrical conduction in the heart","volume":"169","author":"Hulsmans","year":"2017","journal-title":"Cell"},{"key":"10.1038\/s41374-019-0349-z_bib38","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.trsl.2017.10.001","article-title":"Cardiac macrophage biology in the steady-state heart, the aging heart, and following myocardial infarction","volume":"191","author":"Ma","year":"2018","journal-title":"Transl Res"},{"key":"10.1038\/s41374-019-0349-z_bib39","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1084\/jem.20002036","article-title":"Evidence for a role of mast cells in the evolution to congestive heart failure","volume":"195","author":"Hara","year":"2002","journal-title":"J Exp Med"},{"key":"10.1038\/s41374-019-0349-z_bib40","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1084\/jem.20032082","article-title":"A TRPV2-PKA signaling module for transduction of physical stimuli in mast cells","volume":"200","author":"Stokes","year":"2004","journal-title":"J Exp Med"},{"key":"10.1038\/s41374-019-0349-z_bib41","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3389\/fimmu.2012.00150","article-title":"The role of TRP proteins in mast cells","volume":"3","author":"Freichel","year":"2012","journal-title":"Front Immunol"},{"key":"10.1038\/s41374-019-0349-z_bib42","doi-asserted-by":"crossref","first-page":"113","DOI":"10.33549\/physiolres.932053","article-title":"Mast-cell degranulation induced by physical stimuli involves the activation of transient-receptor-potential channel TRPV2","volume":"61","author":"Zhang","year":"2012","journal-title":"Physiol Res"},{"key":"10.1038\/s41374-019-0349-z_bib43","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.carpath.2016.08.004","article-title":"Endoglin selectively modulates transient receptor potential channel expression in left and right heart failure","volume":"25","author":"Morine","year":"2016","journal-title":"Cardiovasc Pathol"},{"issue":"7","key":"10.1038\/s41374-019-0349-z_bib44","doi-asserted-by":"crossref","first-page":"380","DOI":"10.3390\/medicina55070380","article-title":"TRP Channels Expression Profile in Human End-Stage Heart Failure","volume":"55","author":"Drag\u00fan","year":"2019","journal-title":"Medicina"},{"key":"10.1038\/s41374-019-0349-z_bib45","doi-asserted-by":"crossref","first-page":"H157","DOI":"10.1152\/ajpheart.00457.2014","article-title":"Role of TRP channels in the cardiovascular system","volume":"308","author":"Yue","year":"2015","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1038\/s41374-019-0349-z_bib46","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/s41569-018-0145-2","article-title":"Transient receptor potential channels in cardiac health and disease","volume":"16","author":"Hof","year":"2019","journal-title":"Nat Rev Cardiol"},{"key":"10.1038\/s41374-019-0349-z_bib47","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.bbrc.2011.04.124","article-title":"TRPC3-mediated Ca2+ influx contributes to Rac1-mediated production of reactive oxygen species in MLP-deficient mouse hearts","volume":"409","author":"Kitajima","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1038\/s41374-019-0349-z_bib48","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1093\/eurheartj\/ehv250","article-title":"A background Ca2+ entry pathway mediated by TRPC1\/TRPC4 is critical for development of pathological cardiac remodelling","volume":"36","author":"Camacho Londono","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1038\/s41374-019-0349-z_bib49","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ijcard.2016.11.205","article-title":"TRPV1 channels in cardiovascular system: A double edged sword?","volume":"228","author":"Randhawa","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1038\/s41374-019-0349-z_bib50","doi-asserted-by":"crossref","first-page":"491963","DOI":"10.1155\/2014\/491963","article-title":"TRPV1 activation attenuates high-salt diet-induced cardiac hypertrophy and fibrosis through PPAR-delta upregulation","volume":"2014","author":"Gao","year":"2014","journal-title":"PPAR Res"},{"key":"10.1038\/s41374-019-0349-z_bib51","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1093\/ajh\/hpu068","article-title":"Dietary capsaicin ameliorates pressure overload-induced cardiac hypertrophy and fibrosis through the transient receptor potential vanilloid type 1","volume":"27","author":"Wang","year":"2014","journal-title":"Am J Hypertens"},{"key":"10.1038\/s41374-019-0349-z_bib52","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1161\/HYPERTENSIONAHA.114.03699","article-title":"Cardiac sympathetic afferent denervation attenuates cardiac remodeling and improves cardiovascular dysfunction in rats with heart failure","volume":"64","author":"Wang","year":"2014","journal-title":"Hypertension"},{"key":"10.1038\/s41374-019-0349-z_bib53","doi-asserted-by":"crossref","first-page":"5548","DOI":"10.1111\/bph.12987","article-title":"Activation of TRPV1 attenuates high salt-induced cardiac hypertrophy through improvement of mitochondrial function","volume":"172","author":"Lang","year":"2015","journal-title":"Br J Pharmacol"},{"key":"10.1038\/s41374-019-0349-z_bib54","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1177\/1074248417707050","article-title":"A review on potential involvement of TRPV1 channels in ischemia-reperfusion injury","volume":"23","author":"Randhawa","year":"2018","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"10.1038\/s41374-019-0349-z_bib55","doi-asserted-by":"crossref","first-page":"367","DOI":"10.4161\/chan.5.4.17083","article-title":"Mice lacking functional TRPV1 are protected from pressure overload cardiac hypertrophy","volume":"5","author":"Buckley","year":"2011","journal-title":"Channels"},{"key":"10.1038\/s41374-019-0349-z_bib56","doi-asserted-by":"crossref","first-page":"17","DOI":"10.4161\/chan.23006","article-title":"Successful TRPV1 antagonist treatment for cardiac hypertrophy and heart failure in mice","volume":"7","author":"Horton","year":"2013","journal-title":"Channels"},{"key":"10.1038\/s41374-019-0349-z_bib57","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.bbrc.2013.10.128","article-title":"Cold stress accentuates pressure overload-induced cardiac hypertrophy and contractile dysfunction: role of TRPV1\/AMPK-mediated autophagy","volume":"442","author":"Lu","year":"2013","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1038\/s41374-019-0349-z_bib58","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1161\/01.CIR.100.5.461","article-title":"Desmin mutation responsible for idiopathic dilated cardiomyopathy","volume":"100","author":"Li","year":"1999","journal-title":"Circulation"},{"key":"10.1038\/s41374-019-0349-z_bib59","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.nmd.2011.10.019","article-title":"High cardiovascular morbidity and mortality in myofibrillar myopathies due to DES gene mutations: a 10-year longitudinal study","volume":"22","author":"Wahbi","year":"2012","journal-title":"Neuromuscul Disord"},{"key":"10.1038\/s41374-019-0349-z_bib60","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1016\/j.bbadis.2017.07.021","article-title":"An abnormal TRPV4-related cytosolic Ca(2+) rise in response to uniaxial stretch in induced pluripotent stem cells-derived cardiomyocytes from dilated cardiomyopathy patients","volume":"1863","author":"Lu","year":"2017","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"10.1038\/s41374-019-0349-z_bib61","doi-asserted-by":"crossref","first-page":"159ra48","DOI":"10.1126\/scitranslmed.3004276","article-title":"An orally active TRPV4 channel blocker prevents and resolves pulmonary edema induced by heart failure","volume":"4","author":"Thorneloe","year":"2012","journal-title":"Sci Transl Med"},{"key":"10.1038\/s41374-019-0349-z_bib62","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1093\/cvr\/cvy156","article-title":"TRPV4 increases cardiomyocyte calcium cycling and contractility yet contributes to damage in the aged heart following hypoosmotic stress","volume":"115","author":"Jones","year":"2019","journal-title":"Cardiovasc Res"},{"key":"10.1038\/s41374-019-0349-z_bib63","unstructured":"Iwata Y, Wakabayashi S, Ito S, Kitakaze M. Production of TRPV2-targeting functional antibody ameliorating dilated cardiomyopathy and muscular dystrophy in animal models. Under review."},{"key":"10.1038\/s41374-019-0349-z_bib64","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s40520-016-0663-x","article-title":"The role of transient receptor potential vanilloid 2 channel in cardiac aging","volume":"29","author":"Jones","year":"2017","journal-title":"Aging Clin Exp Res"},{"key":"10.1038\/s41374-019-0349-z_bib65","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1161\/CIRCULATIONAHA.109.899294","article-title":"Role of inotropic agents in the treatment of heart failure","volume":"121","author":"Goldhaber","year":"2010","journal-title":"Circulation"},{"key":"10.1038\/s41374-019-0349-z_bib66","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.ijcard.2004.12.012","article-title":"Calcium sensitizer agents: a new class of inotropic agents in the treatment of decompensated heart failure","volume":"103","author":"Perrone","year":"2005","journal-title":"Int J Cardiol"},{"key":"10.1038\/s41374-019-0349-z_bib67","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1126\/science.1200113","article-title":"Cardiac myosin activation: a potential therapeutic approach for systolic heart failure","volume":"331","author":"Malik","year":"2011","journal-title":"Science"},{"key":"10.1038\/s41374-019-0349-z_bib68","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1016\/S0140-6736(16)32049-9","article-title":"Chronic oral study of myosin activation to increase contractility in heart failure (COSMIC-HF): a phase 2, pharmacokinetic, randomised, placebo-controlled trial","volume":"388","author":"Teerlink","year":"2016","journal-title":"Lancet"},{"key":"10.1038\/s41374-019-0349-z_bib69","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1365-2125.2012.04351.x","article-title":"Is the cardiovascular system a therapeutic target for cannabidiol?","volume":"75","author":"Stanley","year":"2012","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"10.1038\/s41374-019-0349-z_bib70","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3390\/md15040087","article-title":"Marine Cyclic Guanidine Alkaloids Monanchomycalin B and Urupocidin A Act as Inhibitors of TRPV1, TRPV2 and TRPV3, but not TRPA1 Receptors","volume":"15","author":"Korolkova","year":"2017","journal-title":"Marine Drugs"},{"key":"10.1038\/s41374-019-0349-z_bib71","doi-asserted-by":"crossref","first-page":"14042","DOI":"10.18632\/oncotarget.24449","article-title":"Novel inhibitor candidates of TRPV2 prevent damage of dystrophic myocytes and ameliorate against dilated cardiomyopathy in a hamster model","volume":"9","author":"Iwata","year":"2018","journal-title":"Oncotarget"},{"key":"10.1038\/s41374-019-0349-z_bib72","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1021\/acs.jmedchem.8b01496","article-title":"Structure-based discovery of a subtype-selective inhibitor targeting a transient receptor potential vanilloid channel","volume":"62","author":"Chai","year":"2019","journal-title":"J Med Chem"},{"key":"10.1038\/s41374-019-0349-z_bib73","doi-asserted-by":"crossref","first-page":"8255","DOI":"10.1021\/acs.jmedchem.8b00734","article-title":"Elongation of the hydrophobic chain as a molecular switch: discovery of capsaicin derivatives and endogenous lipids as potent transient receptor potential vanilloid channel 2 antagonists","volume":"61","author":"Schiano Moriello","year":"2018","journal-title":"J Med Chem"},{"key":"10.1038\/s41374-019-0349-z_bib74","doi-asserted-by":"crossref","first-page":"487","DOI":"10.3389\/fnmol.2018.00487","article-title":"Cannabinoid ligands targeting TRP channels","volume":"11","author":"Muller","year":"2019","journal-title":"Front Mol Neurosci"},{"key":"10.1038\/s41374-019-0349-z_bib75","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.phrs.2014.10.009","article-title":"Tranilast: a review of its therapeutic applications","volume":"91","author":"Darakhshan","year":"2015","journal-title":"Pharmacol Res"},{"key":"10.1038\/s41374-019-0349-z_bib76","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.jacc.2012.11.014","article-title":"Tranilast prevents atrial remodeling and development of atrial fibrillation in a canine model of atrial tachycardia and left ventricular dysfunction","volume":"61","author":"Nakatani","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"16","key":"10.1038\/s41374-019-0349-z_bib77","doi-asserted-by":"crossref","first-page":"3844","DOI":"10.3390\/ijms20163844","article-title":"Blockade of TRPV2 is a Novel Therapy for Cardiomyopathy in Muscular Dystrophy","volume":"20","author":"Iwata","year":"2019","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1038\/s41374-019-0349-z_bib78","doi-asserted-by":"crossref","first-page":"e00291","DOI":"10.1002\/prp2.291","article-title":"Uricosuric targets of tranilast","volume":"5","author":"Mandal","year":"2017","journal-title":"Pharmacol Res Perspect"},{"key":"10.1038\/s41374-019-0349-z_bib79","doi-asserted-by":"crossref","first-page":"e8689","DOI":"10.15252\/emmm.201708689","article-title":"Tranilast directly targets NLRP3 to treat inflammasome-driven diseases.","volume":"10","author":"Huang","year":"2018","journal-title":"EMBO Mol Med."},{"issue":"7","key":"10.1038\/s41374-019-0349-z_bib80","doi-asserted-by":"crossref","first-page":"11960","DOI":"10.1021\/acsomega.9b01228","article-title":"Repurposing of Tranilast for Potential Neuropathic Pain Treatment by Inhibition of Sepiapterin Reductase in the BH4 Pathway","volume":"4","author":"Moore","year":"2019","journal-title":"ACS Omega"},{"key":"10.1038\/s41374-019-0349-z_bib81","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.yjmcc.2012.04.011","article-title":"Probenecid: novel use as a non-injurious positive inotrope acting via cardiac TRPV2 stimulation","volume":"53","author":"Koch","year":"2012","journal-title":"J Mol Cell Cardiol"},{"key":"10.1038\/s41374-019-0349-z_bib82","doi-asserted-by":"crossref","first-page":"G235","DOI":"10.1152\/ajpgi.00256.2012","article-title":"TRPV2 ion channels expressed in inhibitory motor neurons of gastric myenteric plexus contribute to gastric adaptive relaxation and gastric emptying in mice","volume":"304","author":"Mihara","year":"2013","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1038\/s41374-019-0349-z_bib83","doi-asserted-by":"crossref","first-page":"e007148","DOI":"10.1161\/JAHA.117.007148","article-title":"Probenecid improves cardiac function in patients with heart failure with reduced ejection fraction in vivo and cardiomyocyte calcium sensitivity in vitro.","volume":"7","author":"Robbins","year":"2018","journal-title":"J Am Heart Assoc."},{"key":"10.1038\/s41374-019-0349-z_bib84","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.jacc.2017.12.052","article-title":"Cardiovascular risks of probenecid versus allopurinol in older patients with gout","volume":"71","author":"Kim","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1038\/s41374-019-0349-z_bib85","doi-asserted-by":"crossref","first-page":"e93058","DOI":"10.1371\/journal.pone.0093058","article-title":"Probenecid blocks human P2X7 receptor-induced dye uptake via a pannexin-1 independent mechanism","volume":"9","author":"Bhaskaracharya","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1038\/s41374-019-0349-z_bib86","doi-asserted-by":"crossref","first-page":"C761","DOI":"10.1152\/ajpcell.00227.2008","article-title":"Probenecid, a gout remedy, inhibits pannexin 1 channels","volume":"295","author":"Silverman","year":"2008","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1038\/s41374-019-0349-z_bib87","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.ahj.2011.06.012","article-title":"Interleukin-1beta inhibition and the prevention of recurrent cardiovascular events: rationale and design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS)","volume":"162","author":"Ridker","year":"2011","journal-title":"Am Heart J"},{"key":"10.1038\/s41374-019-0349-z_bib88","doi-asserted-by":"crossref","DOI":"10.1038\/srep34995","article-title":"Mechanism of high affinity inhibition of the human urate transporter URAT1","volume":"6","author":"Tan","year":"2016","journal-title":"Sci Rep"},{"key":"10.1038\/s41374-019-0349-z_bib89","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/j.jacc.2010.07.033","article-title":"Cannabidiol attenuates cardiac dysfunction, oxidative stress, fibrosis, and inflammatory and cell death signaling pathways in diabetic cardiomyopathy","volume":"56","author":"Rajesh","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1038\/s41374-019-0349-z_bib90","doi-asserted-by":"crossref","unstructured":"Pumroy RA, Samanta A, Liu Y, Hughes TET, Zhao S, Yudin Y, et al. Molecular mechanism of TRPV2 channel modulation by cannabidiol. 2019 https:\/\/doi.org\/10.1101\/521880","DOI":"10.7554\/eLife.48792.045"},{"key":"10.1038\/s41374-019-0349-z_bib91","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1248\/bpb.19.1109","article-title":"Inhibition of anandamide amidase activity in mouse brain microsomes by cannabinoids","volume":"19","author":"Watanabe","year":"1996","journal-title":"Biol Pharm Bull"},{"key":"10.1038\/s41374-019-0349-z_bib92","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/S0022-3565(24)35376-5","article-title":"Carrier-mediated uptake of the endogenous cannabinoid anandamide in RBL-2H3 cells","volume":"292","author":"Rakhshan","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1038\/s41374-019-0349-z_bib93","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.1167\/iovs.06-1355","article-title":"Involvement of the endocannabinoid system in retinal damage after high intraocular pressure-induced ischemia in rats","volume":"48","author":"Nucci","year":"2007","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"10.1038\/s41374-019-0349-z_bib94","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1177\/1074248408329449","article-title":"Anandamide preserves cardiac function and geometry in an acute doxorubicin cardiotoxicity rat model","volume":"14","author":"Hydock","year":"2009","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"10.1038\/s41374-019-0349-z_bib95","doi-asserted-by":"crossref","first-page":"H610","DOI":"10.1152\/ajpheart.00236.2007","article-title":"Cannabidiol attenuates high glucose-induced endothelial cell inflammatory response and barrier disruption","volume":"293","author":"Rajesh","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1038\/s41374-019-0349-z_bib96","doi-asserted-by":"crossref","DOI":"10.1186\/1742-2094-8-5","article-title":"Cannabidiol reduces lipopolysaccharide-induced vascular changes and inflammation in the mouse brain: an intravital microscopy study","volume":"8","author":"Ruiz-Valdepenas","year":"2011","journal-title":"J Neuroinflamm"}],"container-title":["Laboratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41374-019-0349-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41374-019-0349-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683722012752?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683722012752?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41374-019-0349-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T19:39:11Z","timestamp":1758397151000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0023683722012752"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":96,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S0023683722012752"],"URL":"https:\/\/doi.org\/10.1038\/s41374-019-0349-z","relation":{},"ISSN":["0023-6837"],"issn-type":[{"value":"0023-6837","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TRPV2 channel as a possible drug target for the treatment of heart failure","name":"articletitle","label":"Article Title"},{"value":"Laboratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/s41374-019-0349-z","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}